Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Payables (2023 - 2026)

Adagio Medical Holdings has reported Payables over the past 4 years, most recently at $1.2 million for Q1 2026.

  • Quarterly Payables fell 54.02% to $1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Mar 2026, down 54.02% year-over-year, with the annual reading at $1.1 million for FY2025, 61.9% down from the prior year.
  • Payables was $1.2 million for Q1 2026 at Adagio Medical Holdings, up from $1.1 million in the prior quarter.
  • Over five years, Payables peaked at $40.3 million in Q4 2023 and troughed at $1.0 million in Q3 2025.
  • The 4-year median for Payables is $2.0 million (2025), against an average of $6.9 million.
  • Year-over-year, Payables tumbled 92.95% in 2024 and then tumbled 54.02% in 2026.
  • A 4-year view of Payables shows it stood at $40.3 million in 2023, then tumbled by 92.95% to $2.8 million in 2024, then crashed by 61.9% to $1.1 million in 2025, then rose by 12.48% to $1.2 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Payables are $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025).